To investigate how genetic variations of TF-DNA bindings affect breast cancer susceptibility, we developed an analytic framework to analyze ChIP-seq and breast cancer GWAS summary statistics data (Fig. 1a–c). This evidence concerns the gene TF and breast carcinoma.